These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37170268)

  • 21. Key Population Size Estimation to Guide HIV Epidemic Responses in Nigeria: Bayesian Analysis of 3-Source Capture-Recapture Data.
    McIntyre AF; Mitchell A; Stafford KA; Nwafor SU; Lo J; Sebastian V; Schwitters A; Swaminathan M; Dalhatu I; Charurat M
    JMIR Public Health Surveill; 2022 Oct; 8(10):e34555. PubMed ID: 36287587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability and retention of the key population-led HIV treatment service for men who have sex with men and transgender women living with HIV in Thailand.
    Lujintanon S; Amatavete S; Leenasirimakul P; Meechure J; Noopetch P; Sangtong S; Sittikarn S; Phoopisutthisak P; Seekaew P; Mills S; Phanuphak P; Ramautarsing RA; Phanuphak N
    J Int AIDS Soc; 2023 Feb; 26(2):e26062. PubMed ID: 36757793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring 'generative mechanisms' of the antiretroviral adherence club intervention using the realist approach: a scoping review of research-based antiretroviral treatment adherence theories.
    Mukumbang FC; Van Belle S; Marchal B; van Wyk B
    BMC Public Health; 2017 May; 17(1):385. PubMed ID: 28472938
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Rocha-Jiménez T; Pitpitan EV; Cazares R; Smith LR
    AIDS Patient Care STDS; 2021 Nov; 35(11):449-456. PubMed ID: 34665000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV service delivery in the time of COVID-19: focus group discussions with key populations in India.
    Pollard R; Gopinath U; Reddy YA; Kumar BR; Mugundu P; Vasudevan CK; Srikrishnan AK; Singh A; McFall AM; Mayer KH; Mehta SH; Solomon SS
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25800. PubMed ID: 34713583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual practices, sexual behavior and HIV risk profile of key populations in Nigeria.
    Ochonye B; Folayan MO; Fatusi AO; Bello BM; Ajidagba B; Emmanuel G; Umoh P; Yusuf A; Jaiyebo T
    BMC Public Health; 2019 Sep; 19(1):1210. PubMed ID: 31477063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'At this [
    Mukumbang FC; van Wyk B; Van Belle S; Marchal B
    South Afr J HIV Med; 2019; 20(1):922. PubMed ID: 31308968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Availability and Quality of Surveillance and Survey Data on HIV Prevalence Among Sex Workers, Men Who Have Sex With Men, People Who Inject Drugs, and Transgender Women in Low- and Middle-Income Countries: Review of Available Data (2001-2017).
    Arias Garcia S; Chen J; Calleja JG; Sabin K; Ogbuanu C; Lowrance D; Zhao J
    JMIR Public Health Surveill; 2020 Nov; 6(4):e21688. PubMed ID: 33200996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards Developing an Initial Programme Theory: Programme Designers and Managers Assumptions on the Antiretroviral Treatment Adherence Club Programme in Primary Health Care Facilities in the Metropolitan Area of Western Cape Province, South Africa.
    Mukumbang FC; van Belle S; Marchal B; van Wyk B
    PLoS One; 2016; 11(8):e0161790. PubMed ID: 27560352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV prevalence among men who have sex with men, transgender women and cisgender male sex workers in sub-Saharan Africa: a systematic review and meta-analysis.
    Kloek M; Bulstra CA; van Noord L; Al-Hassany L; Cowan FM; Hontelez JAC
    J Int AIDS Soc; 2022 Nov; 25(11):e26022. PubMed ID: 36419343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring HIV Acquisitions Among Partners of Key Populations: Estimates From HIV Transmission Dynamic Models.
    Silhol R; Anderson RL; Stevens O; Stannah J; Booton RD; Baral S; Dimitrov D; Mitchell KM; Donnell D; Bershteyn A; Brown T; Kelly SL; Kim HY; Johnson LF; Maheu-Giroux M; Martin-Hughes R; Mishra S; Peerapatanapokin W; Stone J; Stover J; Teng Y; Vickerman P; Garcia SA; Korenromp E; Imai-Eaton JW; Boily MC
    J Acquir Immune Defic Syndr; 2024 Jan; 95(1S):e59-e69. PubMed ID: 38180739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unravelling how and why the Antiretroviral Adherence Club Intervention works (or not) in a public health facility: A realist explanatory theory-building case study.
    Mukumbang FC; van Wyk B; Van Belle S; Marchal B
    PLoS One; 2019; 14(1):e0210565. PubMed ID: 30650129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Empirically Derived and Model-Based Estimates of Key Population HIV Incidence and the Distribution of New Infections by Population Group in Sub-Saharan Africa.
    Stevens O; Anderson R; Stover J; Teng Y; Stannah J; Silhol R; Jones H; Booton RD; Martin-Hughes R; Johnson L; Maheu-Giroux M; Mishra S; Stone J; Bershteyn A; Kim HY; Sabin K; Mitchell KM; Dimitrov D; Baral S; Donnell D; Korenromp E; Rice B; Hargreaves JR; Vickerman P; Boily MC; Imai-Eaton JW
    J Acquir Immune Defic Syndr; 2024 Jan; 95(1S):e46-e58. PubMed ID: 38180738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reaching transgender populations in Zambia for HIV prevention and linkage to treatment using community-based service delivery.
    Mwango L; Toeque MG; Lindsay B; Tembo K; Sakala H; Reggee S; Malunga SM; Kabwe M; Kafunda I; Olufunso A; Mwila A; Okuku J; Kancheya N; Nkwemu K; Mumba D; Hachaambwa L; Sheneberger R; Blanco N; Lavoie MC; Stafford KA; Claassen CW
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25995. PubMed ID: 36225155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low engagement in HIV services and progress through the treatment cascade among key populations living with HIV in Mozambique: alarming gaps in knowledge of status.
    Boothe MAS; Sathane I; Baltazar CS; Chicuecue N; Horth R; Fazito E; Raymond HF
    BMC Public Health; 2021 Jan; 21(1):146. PubMed ID: 33451344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial.
    Lujintanon S; Amatavete S; Thitipatarakorn S; Puthanakit T; Songtaweesin WN; Chaisalee T; Janyam S; Phanuphak N; Ramautarsing RA
    Implement Sci Commun; 2022 Oct; 3(1):101. PubMed ID: 36183120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to Accessing Antiretroviral Treatment Among Key Populations in Southwest Nigeria.
    Okonkwo P; Olatoregun OJ; Abolarin O; Olajide O
    Cureus; 2024 Apr; 16(4):e59312. PubMed ID: 38817528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management practices in community-based HIV prevention organizations in Nigeria.
    Akeju D; Nance N; Salas-Ortiz A; Fakunmoju A; Ezirim I; Oluwayinka AG; Godpower O; Bautista-Arredondo S
    BMC Health Serv Res; 2021 May; 21(1):489. PubMed ID: 34022857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing Testing Options for Key Populations in Burundi Through Peer-Assisted HIV Self-Testing: Descriptive Analysis of Routine Programmatic Data.
    Lillie T; Boyee D; Kamariza G; Nkunzimana A; Gashobotse D; Persaud N
    JMIR Public Health Surveill; 2021 Sep; 7(9):e24272. PubMed ID: 34591018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and case finding according to key partner risk populations of people living with HIV in Nigeria: A retrospective analysis of community-led index partner testing services.
    Onovo A; Kalaiwo A; Agweye A; Emmanuel G; Keiser O
    EClinicalMedicine; 2022 Jan; 43():101265. PubMed ID: 35028548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.